2 - Clostridium Difficile Infection Flashcards
(39 cards)
What is clostridium difficile?
- Anaerobic
- Spore forming
- Exotoxin-producing
- Gram pos bacteria
How is C. diff transmitted?
Fecal-oral route
What causes the sx of CDI?
Enterotoxin A and cytotoxin B
NAP1 is associated w/ _______
Fluoroquinolone use
What is the significance of NAP1 C. diff strain?
- Hyper-virulence due to hyper-production of C. perfringens-type toxin
- Higher rates of tx failure, recurrence, complications and attributable mortality compared w/ non-NAP1
Over ___% of CDI associated w/ NAP1
30%
What are the risk factors for CDI?
- Antimicrobial therapy that disrupts normal colonic flora, typically presents w/in 4-9 days
- Previous CDI
- Hospitalization > 72 h
- Female, advanced age (65 and older)
- Multiple co-morbidities, severe underlying disease, immunocompromised
- Gastric acid suppression, enteral feeding, GI surgery, inflammatory bowel disease
Which antibiotics are associated w/ CDI?
- Highest risk = clindamycin
- High risk = fluoroquinolones (NAP1), cephalosporins, penicillins
- Moderate risk = macrolides, sulfonamides
- Low risk = tetracyclines, aminoglycosides
Clinical signs of CDI
- Watery diarrhea w/ 3 or more unformed stools in 24 h
- N/V, abdominal pain, high fever, significant leukocytosis
Normal WBC levels
4.5-11 * 10^9 cells/L or 4,500-11,000 cells/uL
Normal neutrophils levels. When do they increase?
- 1.8-5.2
- Increase significantly during bacterial infections
Normal lymphocyte levels. When do they increase?
- 1.3-3.2
- Increase during viral infections
Normal monocyte levels
0.3-0.8
When do eosinophil levels increase?
Parasite infection or allergies
Complications of CDI
- Most common = recurrence
- Septic shock
- Pseudomembranous or fulminant colitis
- Ileus
- Toxic megacolon (gut is immobile and expands)
- Perforation
How is CDI diagnosed?
- GI sx w/ diarrhea and positive C. difficile toxin in stool
- Stool culture and molecular typing during outbreaks
What is the sensitivity and specificity of the C. difficile assay?
- Sensitivity = 75-80%
- Specificity is very high, so false positives are very rare
Strategies for preventing CDI
- Infection control
- Antimicrobial stewardship for clindamycin, fluoroquinolones, and other high-risk agents
- Probiotics
What can be done to prevent the spread of CDI?
- Environment cleaning and disinfecting
- Healthcare worker hygiene, handwashing (alcohol-based sanitizers not effective against spores)
- Contact and barrier precautions when known or suspected CDI
- Single pt rooms for those w/ known CDI
General approach to treating CDI
- Discontinue offending antimicrobial if possible, or replace w/ lower-risk agent (controversial)
- Supportive measures for hydration and electrolyte balance
- Avoid anti-motility agents
- Antimicrobial therapy for CDI
- Infection control measures
- Surgery for severe, complicated disease
Tx for non-severe CDI
- Metronidazole 500 mg po/ng q8h x 10-14 days (w/ at least 7 days beyond d/c of offending agent)
- Switch to vanco if tx failure
What is the response and recurrence rate to metro for non-severe CDI?
- 90%
- Around 80% for NAP1 and more severe infection
- Recurrence = over 20-25%
What is considered a tx failure of metro for non-severe CDI?
- Lack of clinical improvement w/in 2 days
- Fever lasting 3 or more days
- GI sx lasting 5 or more days
- Worsening clinical status during therapy
Adverse effects of metro for CDI
- GI
- Metallic taste
- Disulfiram-reactions
- CNS (headache, dizziness, confusion)
- Neurotoxicity